Medicare Enrolled

Dr. Erwin Winkel, MD

Optician · Houston, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1140A CYPRESS STATION DR STE 200, Houston, TX 77090
2814447077
In practice since 2006 (19 years)
NPI: 1093874331 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Winkel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Winkel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Winkel

Dr. Erwin Winkel is an optician specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Winkel performed 7,091 Medicare services across 2,153 unique beneficiaries.

Between the years covered by Open Payments, Dr. Winkel received a total of $7,041 from 53 pharmaceutical and/or device companies across 303 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Winkel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 10% volume in TX $7,041 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,091
Medicare services
Top 10% in TX for optician
2,153
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~373 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
MRI contrast dye injection (gadoterate) 2,550 $0 $0
Contrast dye for imaging (iodine-based) 1,600 $0 $0
Urinalysis, manual 1,009 $3 $9
Office visit, established patient (20-29 min) 722 $65 $245
Bladder ultrasound after voiding 445 $8 $29
Office visit, established patient (30-39 min) 196 $92 $352
Diagnostic exam of bladder and urethra using an endoscope 134 $187 $647
Leuprolide acetate (for depot suspension), 7.5 mg 102 $130 $507
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes 56 $65 $249
New patient office visit (30-44 min) 50 $73 $297
New patient office visit (45-59 min) 45 $107 $453
Ultrasound scan of pelvic region through rectum 33 $112 $377
Simple insertion of temporary bladder tube 32 $45 $171
Cell examination of urine, computer-assisted 23 $302 $1,047
Injection, garamycin, gentamicin, up to 80 mg 23 $2 $6
Shock wave crushing of kidney stones 15 $420 $2,038
Crushing of stone of ureter with insertion of stent using an endoscope 15 $330 $1,100
Biopsy of prostate gland 15 $184 $668
Ct scan of abdomen and pelvis before and after contrast 14 $189 $908
Mri scan of pelvis before and after contrast 12 $187 $826
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
66.2% medium
33.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,041
Total received (2018-2024)
Avg $1,006/year across 7 years
Top 22% in TX for optician
53
Companies
303
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,611 (93.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$430 (6.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$935
2023
$1,004
2022
$1,114
2021
$1,163
2020
$642
2019
$1,058
2018
$1,125

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$786
Janssen Biotech, Inc.
$465
NeoTract Inc.
$423
Teleflex LLC
$403
Endo Pharmaceuticals Inc.
$393
ConvaTec Inc.
$389
180 Medical, Inc.
$383
PFIZER INC.
$376
Sumitomo Pharma America, Inc.
$339
BOSTON SCIENTIFIC CORPORATION
$337
Boston Scientific Corporation
$257
UROVANT SCIENCES INC
$214
Dendreon Pharmaceuticals LLC
$186
AbbVie Inc.
$176
Antares Pharma, Inc.
$159
Dornier MedTech America, Inc
$138
ABBVIE INC.
$119
Myovant Sciences Inc.
$116
Ferring Pharmaceuticals Inc.
$114
Coloplast Corp
$113
AbbVie, Inc.
$95
Endo USA, Inc.
$84
AngioDynamics, Inc.
$78
Allergan Inc.
$78
Allergan, Inc.
$61
Retrophin, Inc.
$58
Progenics Pharmaceuticals, Inc.
$48
COLOPLAST CORP
$47
AstraZeneca Pharmaceuticals LP
$43
Travere Therapeutics, Inc.
$38
Acerus Pharmaceuticals Corporation
$38
Supernus Pharmaceuticals, Inc.
$38
UROGEN PHARMA, INC.
$35
Merck Sharp & Dohme Corporation
$28
Agiliti Surgical, Inc.
$26
ACELL, INC.
$26
Medtronic, Inc.
$25
Novartis Pharmaceuticals Corporation
$24
EDAP TECHNOMED INC
$23
PROCEPT BioRobotics Corporation
$23
ABC Home Medical Supply, Inc.
$23
UroGen Pharma, Inc.
$23
Blue Earth Diagnostics Limited
$22
Laborie Medical Technologies Corp.
$20
RGH Enterprises, Inc.
$20
Olympus America Inc.
$19
Amgen Inc.
$19
Hollister Incorporated
$18
MEDIVATION FIELD SOLUTIONS LLC
$16
Merck Sharp & Dohme LLC
$16
GENZYME CORPORATION
$15
TOLMAR Pharmaceuticals, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$13
Top 3 companies account for 23.8% of total payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AFINITOR · AQUABEAM SYSTEM · AVEED · Altis · Androgel · Axumin · BOTOX · BOTOX THERAPEUTIC · BRIDION · CATHETER · CURE HYDRO · EDEX · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GENERAL THERAPIES · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENERAL KIDNEY STONE DISEASE · GENTLECATH · GREENLIGHT · General - BPH · GentleCath · INTERSTIM · JELMYTO · JEVTANA · LUPRON DEPOT · LYNPARZA · Lithotripters & Accessories · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Nubeqa · ORGOVYX · OTREXUP · Olympus Laser Devices · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PROVENGE · PYLARIFY · Porges Coloplast · RESTORELLE · REZUM · Rezum Generator · TLANDO · TOVIAZ · Thiola · Tria Firm · UROLIFT · UroLift · UroLift System · VaPro Pocket · WaveWriter Alpha Prime 16 · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $99 per 100 Medicare services performed
Looking for an optician specialist in Houston?
Compare opticians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
455
Per 100K population
9.6
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE NORTHWEST
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Winkel is a mixed practice specialist, with above-average Medicare volume (top 10% in TX), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Winkel experienced with mri contrast dye injection (gadoterate)?
Based on Medicare claims data, Dr. Winkel performed 2,550 mri contrast dye injection (gadoterate) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Winkel receive payments from pharmaceutical companies?
Yes. Dr. Winkel received a total of $7,041 from 53 companies across 303 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Winkel's costs compare to other opticians in Houston?
Dr. Winkel's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Winkel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →